Human Immunodeficiency Virus
Conditions
Keywords
Option B plus, HIV infected women
Brief summary
The main goal of the study is to support HIV-infected pregnant women initiated on PMTCT Option B+ during antenatal to adhere to lifelong ART and postpartum care visits through an enhanced group peer support intervention called friends for life circles.
Detailed description
The overall goal of this implementation research is to improve retention in care and adherence to ART to 2 years postpartum among HIV infected women in urban and rural Uganda choosing PMTCT Option B+. Formative research will first be conducted to assess knowledge and attitudes regarding Option B+ and lifelong ART among PMTCT clients, community members and health workers. The formative research will inform the design of the group peer support intervention. Interventional research will then be conducted randomizing 540 women to either enhanced group peer support with income generating activities called the Friends for Life Circle (FLC) or MOH standard of care counselling with follow-up to 2 years postpartum. Primary outcomes will include retention in health care, ARV adherence and viral suppression at 6 weeks and 24 months postpartum. Secondary outcomes will include participants' health and economic outcomes.
Interventions
OTHERFriends for Life Circles (FLCs).
The intervention 'Friends for Life Circles (FLCs) will build dynamic peer group support in the community aimed at supporting maternal adherence to appointment keeping and taking lifetime antiretroviral drugs
Sponsors
Johns Hopkins University
MU-JHU CARE
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Age \>18 years * Documentation of pregnancy through clinical assessment or pregnancy test * Documentation of confirmed HIV-positive sero-status at the time of screening * Accepting to receive option B+ for PMTCT * Providing written informed consent to participate in the randomized trial. * Agreeing to come the study clinic for scheduled appointments * Agreeing to be home visited as needed to ensure follow up * Residing within a 20 km radius around the study clinic * Not planning to move out of the catchment area within the next 2 years
Exclusion criteria
\- Social and other circumstances that may prevent the mother from coming back for follow up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Retention | 2 years | in care will be measured as 1 minus proportion of women lost to follow-up at 24 months postpartum |
| Adherence to Option B+ ARV drugs | 2 years | compare maternal antiretroviral drug adherence using self-report, viral load in blood at delivery, 6 weeks, 6 and 24 months postpartum among all HIV-infected pregnant women participating in the study. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Infant HIV Free survival | 2 years | also compare infant HIV-free survival at 6 weeks and 18 months among women randomized to the enhanced community-based intervention (FLC) versus the MOH SOC. Infants born to HIV-infected mothers are tested routinely at 6 weeks of age for HIV DNA by PCR and at 18 months of age by rapid HIV antibody test as part of the national Early Infant HIV Diagnosis program which is standard of care in every government health unit offering postnatal care in Uganda |
| Assessing success and sustainability of FLCs group support activities and IGAs | 2 years | Each FLC will be assessed to see which groups were most successful in developing specific IGAs. The evaluation will be focus on the ability of FLCs to effectively generate income, participant attendance to the circles' IGA-related activities, key skills gained by participants in the circles and the percent increase or decrease in personal and household income |
Countries
Uganda
Outcome results
None listed